{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T15:13:47Z","timestamp":1742397227305},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,10]]},"DOI":"10.7759\/cureus.33608","type":"journal-article","created":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T19:37:38Z","timestamp":1673379458000},"source":"Crossref","is-referenced-by-count":1,"title":["The Effectiveness of Catheter Ablation in the Management of Ventricular Tachycardia in Comparison With Antiarrhythmic Drugs in Patients With Structural Heart Disease: A Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Jithin","family":"Karedath","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia Lisseth","family":"Valle Villatoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sana","family":"Faisal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Indu","family":"Kathuria Anand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venkata","family":"Anirudh Chunchu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Umer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samprith","family":"Ala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adil","family":"Amin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eux077","article-title":"Catheter ablation for ventricular tachycardia in patients with cardiac sarcoidosis: a systematic review","volume":"20","author":"Papageorgiou N","year":"2018","unstructured":"Papageorgiou N, Provid\u00eancia R, Bronis K, Dechering DG, Srinivasan N, Eckardt L, Lambiase PD. Catheter ablation for ventricular tachycardia in patients with cardiac sarcoidosis: a systematic review. Europace. 2018, 20:682-91. 10.1093\/europace\/eux077","journal-title":"Europace"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.963371","article-title":"Catheter ablation of ventricular tachycardia","volume":"122","author":"Tung R","year":"2010","unstructured":"Tung R, Boyle NG, Shivkumar K. Catheter ablation of ventricular tachycardia. Circulation. 2010, 122:e389-91. 10.1161\/CIRCULATIONAHA.110.963371","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv316","article-title":"2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC)","volume":"36","author":"Priori SG","year":"2015","unstructured":"Priori SG, Blomstr\u00f6m-Lundqvist C, Mazzanti A, et al.. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015, 36:2793-867. 10.1093\/eurheartj\/ehv316","journal-title":"Eur Heart J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD014733","article-title":"Catheter ablation versus escalation of antiarrhythmic medications for management of ventricular tachycardia in patients with ischaemic heart disease","volume":"2021","author":"Kakarla J","year":"2021","unstructured":"Kakarla J, Benson C, Abbas M, et al.. Catheter ablation versus escalation of antiarrhythmic medications for management of ventricular tachycardia in patients with ischaemic heart disease. Cochrane Database Syst Rev. 2021, 2021:CD014733. 10.1002\/14651858.CD014733","journal-title":"Cochrane Database Syst Rev"},{"key":"ref5","article-title":"Clinical cardiac electrophysiology: techniques and interpretations","author":"Josephson ME","year":"2008","unstructured":"Josephson ME. Clinical cardiac electrophysiology: techniques and interpretations. Lippincott Williams & Wilkins, Philadelphia, PA; 2008."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2014.07.012","article-title":"Catheter ablation of postinfarction ventricular tachycardia: ten-year trends in utilization, in-hospital complications, and in-hospital mortality in the United States","volume":"11","author":"Palaniswamy C","year":"2014","unstructured":"Palaniswamy C, Kolte D, Harikrishnan P, et al.. Catheter ablation of postinfarction ventricular tachycardia: ten-year trends in utilization, in-hospital complications, and in-hospital mortality in the United States. Heart Rhythm. 2014, 11:2056-63. 10.1016\/j.hrthm.2014.07.012","journal-title":"Heart Rhythm"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/JCMA.0000000000000137","article-title":"Role of catheter ablation in patients with ischemic ventricular tachycardia: from basic to clinical practice","volume":"82","author":"Chang TY","year":"2019","unstructured":"Chang TY, Lin CY, Chung FP, et al.. Role of catheter ablation in patients with ischemic ventricular tachycardia: from basic to clinical practice. J Chin Med Assoc. 2019, 82:609-15. 10.1097\/JCMA.0000000000000137","journal-title":"J Chin Med Assoc"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/jce.12567","article-title":"Catheter ablation for ventricular tachycardia in patients with an implantable cardioverter defibrillator (CALYPSO) pilot trial","volume":"26","author":"Al-Khatib SM","year":"2015","unstructured":"Al-Khatib SM, Daubert JP, Anstrom KJ, et al.. Catheter ablation for ventricular tachycardia in patients with an implantable cardioverter defibrillator (CALYPSO) pilot trial. J Cardiovasc Electrophysiol. 2015, 26:151-7. 10.1111\/jce.12567","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.01.050","article-title":"Substrate ablation vs antiarrhythmic drug therapy for symptomatic ventricular tachycardia","volume":"79","author":"Arenal \u00c1","year":"2022","unstructured":"Arenal \u00c1, \u00c1vila P, Jim\u00e9nez-Candil J, et al.. Substrate ablation vs antiarrhythmic drug therapy for symptomatic ventricular tachycardia. J Am Coll Cardiol. 2022, 79:1441-53. 10.1016\/j.jacc.2022.01.050","journal-title":"J Am Coll Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1513614","article-title":"Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs","volume":"375","author":"Sapp JL","year":"2016","unstructured":"Sapp JL, Wells GA, Parkash R, et al.. Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. N Engl J Med. 2016, 375:111-21. 10.1056\/NEJMoa1513614","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2019.05.026","article-title":"Catheter ablation versus medical therapy for treatment of ventricular tachycardia associated with structural heart disease: systematic review and meta-analysis of randomized controlled trials and comparison with observational studies","volume":"16","author":"Anderson RD","year":"2019","unstructured":"Anderson RD, Ariyarathna N, Lee G, et al.. Catheter ablation versus medical therapy for treatment of ventricular tachycardia associated with structural heart disease: systematic review and meta-analysis of randomized controlled trials and comparison with observational studies. Heart Rhythm. 2019, 16:1484-91. 10.1016\/j.hrthm.2019.05.026","journal-title":"Heart Rhythm"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2019.04.024","article-title":"Systematic review and meta-analysis of catheter ablation of ventricular tachycardia in ischemic heart disease","volume":"17","author":"Martinez BK","year":"2020","unstructured":"Martinez BK, Baker WL, Konopka A, Giannelli D, Coleman CI, Kluger J, Cronin EM. Systematic review and meta-analysis of catheter ablation of ventricular tachycardia in ischemic heart disease. Heart Rhythm. 2020, 17:e206-19. 10.1016\/j.hrthm.2019.04.024","journal-title":"Heart Rhythm"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e31825d59fd","article-title":"Educational and psychological interventions to improve outcomes for recipients of implantable cardioverter defibrillators and their families: a scientific statement from the American Heart Association","volume":"126","author":"Dunbar SB","year":"2012","unstructured":"Dunbar SB, Dougherty CM, Sears SF, et al.. Educational and psychological interventions to improve outcomes for recipients of implantable cardioverter defibrillators and their families: a scientific statement from the American Heart Association. Circulation. 2012, 126:2146-72. 10.1161\/CIR.0b013e31825d59fd","journal-title":"Circulation"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eup098","article-title":"EHRA\/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA)","volume":"11","author":"Aliot EM","year":"2009","unstructured":"Aliot EM, Stevenson WG, Almendral-Garrote JM, et al.. EHRA\/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA). Europace. 2009, 11:771-817. 10.1093\/europace\/eup098","journal-title":"Europace"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2016.03.004","article-title":"Comparative effectiveness of antiarrhythmic drugs and catheter ablation for the prevention of recurrent ventricular tachycardia in patients with implantable cardioverter-defibrillators: a systematic review and meta-analysis of randomized controlled trials","volume":"13","author":"Santangeli P","year":"2016","unstructured":"Santangeli P, Muser D, Maeda S, et al.. Comparative effectiveness of antiarrhythmic drugs and catheter ablation for the prevention of recurrent ventricular tachycardia in patients with implantable cardioverter-defibrillators: a systematic review and meta-analysis of randomized controlled trials. Heart Rhythm. 2016, 13:1552-9. 10.1016\/j.hrthm.2016.03.004","journal-title":"Heart Rhythm"},{"key":"ref16","doi-asserted-by":"crossref","DOI":"10.1016\/S0735-1097(98)81159-5","article-title":"Randomized controlled trial of ventricular tachycardia treatment by cooled tip catheter ablation vs drug therapy","volume":"31","author":"Epstein AE","year":"1998","unstructured":"Epstein AE, Wilber DJ, Calkins H, et al.. Randomized controlled trial of ventricular tachycardia treatment by cooled tip catheter ablation vs drug therapy. J Am Coll Cardiol. 1998, 31:118.","journal-title":"J Am Coll Cardiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000549","article-title":"2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"138","author":"Al-Khatib SM","year":"2018","unstructured":"Al-Khatib SM, Stevenson WG, Ackerman MJ, et al.. 2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2018, 138:e272-391. 10.1161\/CIR.0000000000000549","journal-title":"Circulation"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/132757-the-effectiveness-of-catheter-ablation-in-the-management-of-ventricular-tachycardia-in-comparison-with-antiarrhythmic-drugs-in-patients-with-structural-heart-disease-a-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:53:23Z","timestamp":1707508403000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/132757-the-effectiveness-of-catheter-ablation-in-the-management-of-ventricular-tachycardia-in-comparison-with-antiarrhythmic-drugs-in-patients-with-structural-heart-disease-a-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,10]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.33608","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,10]]}}}